Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | GLO1 | Q04760 | 2/20 | 0.36 |
| ▸ | KMO | O15229 | 1/20 | 0.36 |
| ▸ | GP6 | Q9HCN6 | 1/20 | 0.36 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | DHODH | Q02127 | 1/20 | 0.34 |
| ▸ | KDR | P35968 | 1/20 | 0.34 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.34 |
| ▸ | TET1 | Q8NFU7 | 1/20 | 0.34 |
| ▸ | PSMB8 | P28062 | 1/20 | 0.33 |
| ▸ | ALPL | P05186 | 1/20 | 0.33 |
| ▸ | ALPI | P09923 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23076197 | 0.90 | L3MBTL1 (0.46) | L3MBTL1GLO1HSP90AA1ALDH1A1KDR | |
| SCHEMBL23076202 | 0.86 | PLA2G2A (0.39) | L3MBTL1ALDH1A1 | |
| SCHEMBL21709308 | 0.72 | GP6 (0.53) | L3MBTL1KMOGP6ALDH1A1DHODH | |
| SCHEMBL23610500 | 0.70 | L3MBTL1 (0.54) | L3MBTL1KMOGP6ALDH1A1DHODH | |
| SCHEMBL21125874 | 0.70 | GP6 (0.52) | L3MBTL1KMOGP6ALDH1A1DHODH | |
| SCHEMBL22485913 | 0.70 | GP6 (0.52) | L3MBTL1KMOGP6ALDH1A1DHODH | |
| SCHEMBL24648166 | 0.70 | L3MBTL1 (0.54) | L3MBTL1KMOGP6ALDH1A1DHODH | |
| SCHEMBL24838440 | 0.70 | GP6 (0.52) | L3MBTL1KMOGP6ALDH1A1DHODH | |
| SCHEMBL24837173 | 0.70 | L3MBTL1 (0.54) | L3MBTL1KMOGP6ALDH1A1DHODH | |
| SCHEMBL18134328 | 0.70 | L3MBTL1 (0.54) | L3MBTL1KMOGP6ALDH1A1DHODH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220310932-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2022-09-29 | — | — | US | disclosed |
| WO-2021043703-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2021-03-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220310932-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | OR10J3, EPCAM, L1CAM | L3MBTL1 1415/4885GLO1 1153/4885KMO 2278/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.